Macalma, Monera .
HRN: 27-33-22 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2025
CEFUROXIME 750MG (VIAL)
12/21/2025
12/27/2025
IV
750mg
Q8
Breast Carcinoma
Checking Initial Appropriateness